CM
CPRX

Caption Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Caption Management’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-12,000
Closed -$64K – 846
2019
Q3 		$64K Hold
12,000
– – ﹤0.01% 646
2019
Q2 		$46K Buy
+12,000
New +$51.8K ﹤0.01% 630

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Caption Management's CPRX Position: Q4 2019 in Review

Caption Management sold out of Catalyst Pharmaceutical (CPRX) in Q4 2019, closing a stake of 12,000 shares — an estimated $64K sold.

Caption Management first reported a position in CPRX in Q2 2019 and held it in 2 quarters. The position peaked at $64K in Q3 2019. 130 funds tracked by Wall St. Rank hold CPRX as of Q4 2019.

  • Caption Management reported no remaining Catalyst Pharmaceutical position as of Q4 2019 after selling out during the quarter.
  • Caption Management sold 12,000 Catalyst Pharmaceutical shares in Q4 2019, an estimated $64K.
  • Caption Management first reported a position in Catalyst Pharmaceutical in Q2 2019 and held it in 2 quarters.
  • Caption Management's Catalyst Pharmaceutical position peaked at $64K in Q3 2019.
  • 130 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q4 2019.

Based on Caption Management's 13F filing for Q4 2019, filed 13 Feb 2020.